Baraclude 1.0 mg film coated tablets

  • Name:

    Baraclude 1.0 mg film coated tablets

  • Company:
    info
  • Active Ingredients:

    Entecavir monohydrate

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 21/05/19

files-icon(Click to Download)

XPIL

Summary of Product Characteristics last updated on medicines.ie: 22/2/2019

Click on this link to Download PDF directly

Bristol-Myers Squibb Pharma EEIG

Company Products

Medicine NameActive Ingredients
Medicine Name Baraclude 0.05 mg/ml oral solution Active Ingredients Entecavir monohydrate
Medicine Name Baraclude 0.5 mg film coated tablets Active Ingredients Entecavir monohydrate
Medicine Name Baraclude 1.0 mg film coated tablets Active Ingredients Entecavir monohydrate
Medicine Name Empliciti 300 mg and 400 mg powder for concentrate for solution for infusion Active Ingredients Elotuzumab
Medicine Name NULOJIX 250 mg powder for concentrate for solution for infusion Active Ingredients Belatacept
Medicine Name OPDIVO 10 mg/mL concentrate for solution for infusion Active Ingredients Nivolumab
Medicine Name ORENCIA 125 mg solution for injection in pre-filled pen Active Ingredients Abatacept
Medicine Name ORENCIA 250 mg powder for concentrate for solution for infusion Active Ingredients Abatacept
Medicine Name ORENCIA 50 mg, 87.5 mg and 125 mg solution for injection (pre-filled syringe) Active Ingredients Abatacept
Medicine Name Reyataz 150 mg Hard Capsules Active Ingredients Atazanavir sulfate
Medicine Name Reyataz 200 mg Hard Capsules Active Ingredients Atazanavir sulfate
Medicine Name Reyataz 300 mg Hard Capsules Active Ingredients Atazanavir sulfate
Medicine Name Sprycel 10 mg/mL powder for oral suspension Active Ingredients dasatinib monohydrate
Medicine Name Sprycel 20mg, 50mg, 70mg and 100mg Film-Coated Tablets Active Ingredients dasatinib monohydrate
Medicine Name Sustiva 50 mg , 100 mg , 200 mg Hard Capsules Active Ingredients Efavirenz
Medicine Name Sustiva 600 mg Film-coated Tablets Active Ingredients Efavirenz
Medicine Name Yervoy 5mg per ml concentrate for solution for infusion Active Ingredients ipilimumab
Medicine Name Zerit 30 mg capsules Active Ingredients Stavudine
Medicine Name Zerit 40 mg capsules Active Ingredients Stavudine
1 - 0 of 19 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 21 May 2019 PIL

Reasons for updating

  • Change to section 6 - date of revision

Updated on 25 February 2019 PIL

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Updated on 22 February 2019 SmPC

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

The address of the Marketing Authorisation Holder has been changed

Updated on 20 September 2018 PIL

Reasons for updating

  • Change to section 6 - date of revision
  • Change to MA holder contact details

Updated on 20 September 2018 SmPC

Reasons for updating

  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 10 - Date of revision of the text
  • Correction of spelling/typing errors

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 29 June 2018 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 29 June 2018 PIL

Reasons for updating

  • Change to section 6 - date of revision
  • Correction of spelling/typing errors

Updated on 1 September 2014 PIL

Reasons for updating

  • New PIL for new product

Updated on 1 September 2014 PIL

Reasons for updating

  • Change to packaging
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change to dosage and administration
  • Changes to therapeutic indications
  • Correction of spelling/typing errors

Updated on 29 January 2014 PIL

Reasons for updating

  • Change to side-effects
  • Change to date of revision

Updated on 2 November 2012 PIL

Reasons for updating

  • Change to warnings or special precautions for use

Updated on 17 August 2012 PIL

Reasons for updating

  • Correction of spelling/typing errors
  • Improved electronic presentation

Updated on 27 May 2011 PIL

Reasons for updating

  • Change to, or new use for medicine
  • Change to further information section

Updated on 4 March 2011 PIL

Reasons for updating

  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects

Updated on 26 November 2010 PIL

Reasons for updating

  • Addition of manufacturer

Updated on 27 September 2010 PIL

Reasons for updating

  • Change to improve clarity and readability

Updated on 10 September 2010 PIL

Reasons for updating

  • Change to side-effects
  • Change to information about pregnancy or lactation

Updated on 26 August 2009 PIL

Reasons for updating

  • Change to side-effects
  • Change to date of revision
  • Change of inactive ingredient

Updated on 7 October 2008 PIL

Reasons for updating

  • New PIL for medicines.ie